Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2018, 27(4):174-183

Kardiológia v roku 2017. Aorta a periférna cirkulácia

Victor Aboyans*,1,2, Sigrid Braekkan3, Lucia Mazzolai4, Henrik Sillesen5, Maarit Venermo6, $Marco De Carlo7, ESC Working Group on Aorta Peripheral Vascular Diseases
1 Department of Cardiology, Dupuytren University Hospital 2, Martin Luther King Ave., Limoges, France
2 Inserm 1094, Limoges School of Medicine, Ave Dr. Marcland, 87025 Limoges, France
3 K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Hansine Hansens veg 18, 9037, Troms, Norway
4 Division of Angiology, Department of Heart and Vessel, Lausanne University Hospital, Ch du Mont-Paisible 18, Lausanne, 1011, Switzerland
6 Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, 2100, Denmark; 6Department of Vascular Surgery, Helsinki University Hospital, Haartmaninkatu 4, FI-00290 Helsinki, Finland
7 Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospealiero-Universitaria Pisana, via Paradisa, Pisa, Italy

Uverejnené: April 1, 2018  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Aboyans V, Braekkan S, Mazzolai L, Sillesen H, Venermo M, De Carlo $, ESC Working Group on Aorta Peripheral Vascular Diseases. Kardiológia v roku 2017. Aorta a periférna cirkulácia. Cardiology Letters. 2018;27(4):174-183.
Stiahnuť citáciu

Referencie

  1. Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, Wilkins E, Wright L, Vos R, Bax J, Blum M, Pinto F, Vardas P. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J 2017; doi: 10.1093/eurheartj/ehx628 [Epub ahead of print]. Prejsť k pôvodnému zdroju...
  2. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, EspinolaKlein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 2017; doi:10.1093/eurheartj/ehx095. Prejsť k pôvodnému zdroju...
  3. Lindholt JS, Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017;390:2256-2265. Prejsť k pôvodnému zdroju...
  4. Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; doi:10.1016/S0140-6736(17)32409-1. Prejsť k pôvodnému zdroju...
  5. Moresoli P, Habib B, Reynier P, Secrest MH, Eisenberg MJ, Filion KB. Carotid stenting versus endarterectomy for asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Stroke 2017;48:2150-2157. Prejsť k pôvodnému zdroju...
  6. Verma S, Mazer CD, Al-Omran M, Inzucchi SE, Fitchett D, Hehnke U, George JT, Zinman B. Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG OUTCOME. Circulation 2017: doi: 10.1161/CIRCULATIONAHA.117.032031 [Epub ahead of print]. Prejsť k pôvodnému zdroju...
  7. Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Lowdensity lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation 2017; doi: 10.1161/CIRCULATIONAHA.117.032235. Prejsť k pôvodnému zdroju...
  8. Krankenberg H, Zeller T, Ingwersen M, Schmalstieg J, Gissler HM, Nikol S, Baumgartner I, Diehm N, Nickling E, MüllerHülsbeck S, Schmiedel R, Torsello G, Hochholzer W, Stelzner C, Brechtel K, Ito W, Kickuth R, Blessing E, Thieme M, Nakonieczny J, Nolte T, Gareis R, Boden H, Sixt S. Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv 2017;10:1694-1704. Prejsť k pôvodnému zdroju...
  9. Ott I, Cassese S, Groha P, Steppich B, Hadamitzky M, Ibrahim T, Kufner S, Dewitz K, Hiendlmayer R, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M. Randomized comparison of paclitaxeleluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISARSTATH). Circulation 2017;135:2218-2226. Prejsť k pôvodnému zdroju...
  10. Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, Cardenas J, Werner M, Brodmann M, Mustapha JA, Mena-Hurtado C, Jaff MR, Holden AH, Lyden SP. Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation 2017;136:1102-1113. Prejsť k pôvodnému zdroju...
  11. Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M; ILLUMENATE EU RCT Investigators. Low-dose paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Circulation 2017;135:2227-2236. Prejsť k pôvodnému zdroju...
  12. Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P. Investigators EC. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017;376:1211-1222. Prejsť k pôvodnému zdroju...
  13. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C. ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017;377:2240-2252. Prejsť k pôvodnému zdroju...
  14. Verma AA, Masoom H, Rawal S, Guo Y, Razak F. Investigators G. Pulmonary embolism and deep venous thrombosis in patients hospitalized with syncope: a multicenter crosssectional study in Toronto, Ontario, Canada. JAMA Intern Med 2017;177:1046-1048. Prejsť k pôvodnému zdroju...
  15. Darmon A, Bhatt DL, Elbez Y, Aboyans V, Anand S, Bosch J, Branch K, Conolly SJ, Dyal L, Eikelboom JW, Fox KAA, Keltai K, Probstfield J, Yusuf S, Abtan J, Sorbets E, Eagle KA, Ducrocq G, Steg PG. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry. Eur Heart J 2017; doi:10.1093/eurheartj/ehx658. Prejsť k pôvodnému zdroju...
  16. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR. CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017;377:644-657. Prejsť k pôvodnému zdroju...
  17. Freisinger E, Malyar NM, Reinecke H, Lawall H. Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis. Cardiovasc Diabetol 2017;16:41. Prejsť k pôvodnému zdroju...
  18. Kolte D, Kennedy KF, Shishehbor MH, Abbott JD, Khera S, Soukas P, Mamdani ST, Hyder ON, Drachman DE, Aronow HD. Thirtyday readmissions after endovascular or surgical therapy for critical limb ischemia: analysis of the 2013 to 2014 nationwide readmissions databases. Circulation 2017;136:167-176. Prejsť k pôvodnému zdroju...
  19. Jaff MR, Nelson T, Ferko N, Martinson M, Anderson LH, Hollmann S. Endovascular interventions for femoropopliteal peripheral artery disease: a network meta-analysis of current technologies. J Vasc Interv Radiol 2017;28:1617-1627. Prejsť k pôvodnému zdroju...
  20. Smilowitz NR, Gupta N, Guo Y, Berger JS, Bangalore S. Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J 2017;38:2409-2417. Prejsť k pôvodnému zdroju...
  21. Shah Z, Masoomi R, Thapa R, Wani M, Chen J, Dawn B, Rymer M, Gupta K. Optimal medical management reduces risk of disease progression and ischemic events in asymptomatic carotid stenosis patients: a long-term follow-up study. Cerebrovasc Dis 2017;44:150-159. Prejsť k pôvodnému zdroju...
  22. Bennett KM, Scarborough JE. Carotid artery stenting is associated with a higher incidence of major adverse clinical events than carotid endarterectomy in female patients. J Vasc Surg 2017;66:794-801. Prejsť k pôvodnému zdroju...
  23. Rantner B, Kollerits B, Roubin GS, Rantner B, Kollerits B, Roubin GS, Ringleb PA, Jansen O, Howard G, Hendrikse J, Halliday A, Gregson J, Eckstein HH, Calvet D, Bulbulia R, Bonati LH, Becquemin JP, Algra A, Brown MM, Mas JL, Brott TG, Fraedrich G. Carotid Stenosis Trialists' Collaboration. Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials. Stroke 2017;48:1580-1587. Prejsť k pôvodnému zdroju...
  24. Knappich C, Kuehnl A, Tsantilas P, Schmid S, Breitkreuz T, Kallmayer M, Zimmermann A, Eckstein HH. The use of embolic protection devices is associated with a lower stroke and death rate after carotid stenting. JACC Cardiovasc Interv 2017;10:1257-1265. Prejsť k pôvodnému zdroju...
  25. Venermo M, Wang G, Sedrakyan A, Mao J, Eldrup N, DeMartino R, Mani K, Altreuther M, Beiles B, Menyhei G, Danielsson G, Thomson I, Heller G, Setacci C, Björck M, Cronenwett J. Editor's choice - carotid stenosis treatment: variation in international practice patterns. Eur J Vasc Endovasc Surg 2017;53:511-519. Prejsť k pôvodnému zdroju...
  26. Saura D, Dulgheru R, Caballero L, Bernard A, Kou S, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Van De Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Gori AS, Cosyns B, Donal E, Habib G, Addetia K, Lang RM, Badano LP, Lancellotti P. Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 2017;18:167-179. Prejsť k pôvodnému zdroju...
  27. Thomas IC, McClelland RL, Michos ED, Allison MA, Forbang NI, Longstreth WT Jr, Post WS, Wong ND, Budoff MJ, Criqui MH. Density of calcium in the ascending thoracic aorta and risk of incident cardiovascular disease events. Atherosclerosis 2017;265:190-196. Prejsť k pôvodnému zdroju...
  28. Kim J, Budoff MJ, Nasir K, Wong ND, Yeboah J, Al-Mallah MH, Shea S, Dardari ZA, Blumenthal RS, Blaha MJ, Cainzos-Achirica M. Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2017;257:1-8. Prejsť k pôvodnému zdroju...
  29. Ohyama Y, Ambale-Venkatesh B, Noda C, Kim JY, Tanami Y, Teixido-Tura G, Chugh AR, Redheuil A, Liu CY, Wu CO, Hundley WG, Bluemke DA, Guallar E, Lima JAC. Aortic arch pulse wave velocity assessed by magnetic resonance imaging as a predictor of incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis). Hypertension 2017;70:524-530. Prejsť k pôvodnému zdroju...
  30. Lescan M, Veseli K, Oikonomou A, Walker T, Lausberg H, Blumenstock G, Bamberg F, Schlensak C, Krüger T. Aortic elongation and Stanford B dissection: the Tübingen Aortic Pathoanatomy (TAIPAN) Project. Eur J Vasc Endovasc Surg 2017;54:164-169. Prejsť k pôvodnému zdroju...
  31. Craiem D, El Batti S, Casciaro ME, Mousseaux E, Sirieix ME, Simon A, Alsac JM. Age-related changes of thoracic aorta geometry used to predict the risk for acute type B dissection. Int J Cardiol 2017;228:654-660. Prejsť k pôvodnému zdroju...
  32. Ghulam QM1, Bredahl KK2, Lönn L, Rouet L, Sillesen HH5. Eiberg JP6: follow-up on small abdominal aortic aneurysms using three dimensional ultrasound: volume versus diameter. Eur J Vasc Endovasc Surg 2017;54:439-445.
  33. Laine MT, Laukontaus SJ, Sund R, Aho PS, Kantonen I, Albäck A, Venermo M. A population-based study of abdominal aortic aneurysm treatment in Finland 2000 to 2014. Circulation 2017;136:1726-1734. Prejsť k pôvodnému zdroju...
  34. Budtz-Lilly J, Venermo M, Debus S, Behrendt CA, Altreuther M, Beiles B, Szeberin Z, Eldrup N, Danielsson G, Thomson I, Wigger P, Björck M, Loftus I, Mani K. Assessment of international outcomes of intact abdominal aortic aneurysm repair over 9 years. Eur J Vasc Endovasc Surg 2017;54:13-20. Prejsť k pôvodnému zdroju...
  35. Tomee SM, Bastiaannet E, Schermerhorn ML, Golledge J, Hamming JF, Lindeman JH. The consequences of real life practice of early abdominal aortic aneurysm repair: a cost-benefit analysis. Eur J Vasc Endovasc Surg 2017;54:28-33. Prejsť k pôvodnému zdroju...
  36. Abraha I, Luchetta ML, De Florio R, Cozzolino F, Casazza G, Duca P, Parente B, Orso M, Germani A, Eusebi P, Montedori A. Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair. Cochrane Database Syst Rev 2017;6:CD010296. Prejsť k pôvodnému zdroju...
  37. Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MP, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Eur Heart J 2017; doi:10.1093/eurheartj/ehx003. Prejsť k pôvodnému zdroju...
  38. Prandoni P, Vedovetto V, Ciammaichella M, Bucherini E, Corradini S, Enea I, Cosmi B, Mumoli N, Visona A, Barillari G, Bova C, Quintavalla R, Zanatta N, Pedrini S, Villalta S, Camporese G, Testa S, Parisi R, Becattini C, Cuppini S, Pengo V, Palareti G, Morgagni I. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis. Thromb Res 2017;154:35-41. Prejsť k pôvodnému zdroju...
  39. De Carlo M, Mazzolai L, Bossone E, Brodmann M, Micari A, Muiesan ML, Ricco JB, Stabile E, Agnelli G, Aboyans V. ESC Working Group on Aorta and Peripheral Vascular Diseases. The year in cardiology 2016: peripheral circulation. Eur Heart J 2017;38:1028-1033. Prejsť k pôvodnému zdroju...
  40. Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ. Investigators RIS. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ 2017;356:j1065. Prejsť k pôvodnému zdroju...
  41. Prandoni P, Ageno W, Mumoli N, Zanatta N, Imberti D, Visonà A, Ciammaichella M, Simioni L, Cappelli R, Bucherini E, Di Nisio M, Avruscio G, Camporese G, Parisi R, Cuppini S, Turatti G, Noventa F, Sarolo L. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res 2017;153:97-100. Prejsť k pôvodnému zdroju...
  42. Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbaek G, Sandset PM. CaVenT Study Group. Postthrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomized controlled trial. Lancet Haematol 2016;3:e64-e71. Prejsť k pôvodnému zdroju...
  43. van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten H-M, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, De Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen PW, Büller HR. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica 2017;102:1494-1501. Prejsť k pôvodnému zdroju...
  44. Alatri A, Mazzolai L, Font C, Tafur A, Valle R, Marchena PJ, Ballaz A, Tiraferri E, Font L, Monreal M, Riete Investigators T. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE Registry. Thromb Haemost 2017;117:1630-1636. Prejsť k pôvodnému zdroju...
  45. Alatri A, Mazzolai L, Kucher N, Aujesky D, Beer JH, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Engelberger RP, Baumgartner I, Spirk D. The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry. Semin Thromb Hemost 2017;43:871876. Prejsť k pôvodnému zdroju...
  46. van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, ten Wolde M, Klok FA, Huisman MV, Fogteloo AJ, Kroft LJM, Brekelmans MP, Vermaire RMJ, Bastiaansen-Bergsma H, Biedermann JS, Klijn A, van der Voort S, Lieveld AWE, de Jong PY, Schaar CG, del Sol AI. group Ys. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 2017;390:289-297. Prejsť k pôvodnému zdroju...
  47. Robert-Ebadi H, Glauser F, Planquette B, Moumneh T, Le Gal G, Righini M. Safety of multidetector computed tomography pulmonary angiography to exclude pulmonary embolism in patients with a likely pretest clinical probability. J Thromb Haemost 2017;15:1584-1590. Prejsť k pôvodnému zdroju...
  48. Oqab Z, Ganshorn H, Sheldon R. Prevalence of pulmonary embolism in patients presenting with syncope. A systematic review and meta-analysis. Am J Emerg Med 2017; doi:10.1016/j.ajem.2017.09.015. Prejsť k pôvodnému zdroju...
  49. Frizell A, Fogel N, Steenblik J, Carlson M, Bledsoe J, Madsen T. Prevalence of pulmonary embolism in patients presenting to the emergency department with syncope. Am J Emerg Med 2017; doi:10.1016/j.ajem.2017.07.090. Prejsť k pôvodnému zdroju...
  50. Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galie N, Jimenez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017;69:1536-1544. Prejsť k pôvodnému zdroju...